Moderna | MRNA - Operating Expenses


Moderna reported $1.78B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 272.68M 6.08M Mar/2026
Agios Pharmaceuticals USD 130.77M 10.77M Mar/2026
Alnylam Pharmaceuticals USD 898.54M 66.78M Mar/2026
Amgen USD 4.78B 1.12B Mar/2026
Arrowhead Research USD 215M 8.23M Mar/2026
Biogen USD 1.96B 69.6M Mar/2026
BioMarin Pharmaceutical USD 636.56M 39.61M Mar/2026
Celltrion KRW 140.68B 584.31B Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Divis Laboratories Ltd INR 20.17B 1.85B Mar/2026
Esperion Therapeutics USD 83.21M 14.06M Dec/2025
Gilead Sciences USD 23.52B 18.55B Mar/2026
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
Incyte USD 5.62B 4.5B Mar/2026
Ionis Pharmaceuticals USD 364M 54M Mar/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 1.78B 242M Mar/2026
Organigram Holdings CAD 83.66M 24.44M Dec/2025
Ovoca Bio EUR 1.16M 4.48M Jun/2025
Pharma Mar EUR 42.28M 4.59M Mar/2026
Puma Biotechnology USD 49.26M 3.2M Jun/2024
Qiagen NV USD 418.54M 23.25M Dec/2025
Regeneron Pharmaceuticals USD 31.42B 28.44B Mar/2026
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sarepta Therapeutics USD 372.37M 480.65M Mar/2026
Sartorius EUR 738.4M 22.4M Mar/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025
Ultragenyx Pharmaceutical USD 305M 16M Mar/2026
United Therapeutics USD 5.9B 5.1B Mar/2026
Vertex Pharmaceuticals USD 1.85B 78.6M Mar/2026
Zealand Pharma A/S 775.97M 265.08M Dec/2025
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026